Pomegranate effects on the health aspects of women during peri‐ and postmenopause: A systematic review and meta‐analysis

• Published in: Phytotherapy research 2024-01, Vol.38 (1), p.368-383
• Main Authors: Moeini, Reihaneh, Shirafkan, Hoda, Gorji, Narjes
• Format: Article
• Language: English
• Subjects: Body mass; Body mass index; Body size; Density; Dietary Supplements; estradiol; Female; Follicle-stimulating hormone; Fruit; Heterogeneity; hot flashes; Hot Flashes - diet therapy; Humans; Menopause; Meta-analysis; metabolic syndrome; oxidative stress; pomegranate; Pomegranate - chemistry; Post-menopause; Postmenopause; Quality assessment; Quality control; Randomization; Randomized Controlled Trials as Topic; Search engines; Signs and symptoms; Womens health
• ISSN: 0951-418X; 1099-1573
• DOI: 10.1002/ptr.8036

Pomegranate is widely used to preserve human health and help prevent many kinds of diseases. This study aims to review and assess the effects of pomegranate on women's health during and after menopause. PubMed, Web of science, Cochrane, Scopus, and Google Scholar were searched up to the end of 2022 with no language or study type restriction. All types of clinical research studies (randomized clinical trial [RCT], pre–post, case report, and case series) were included. The Cochrane RoB 2.0 tool was used for quality assessment of RCTs. A summary of intervention's effects for each study was provided by calculating standardized mean differences and accompanying 95% confidence interval using random effect model. Weighted mean differences and heterogeneity between studies were assessed using Hedges's method and Cochran's Q test, respectively. Pomegranate can significantly improve hot flashes severity and menopause symptoms and decrease FSH. It significantly improves high‐density lipoprotein but not low‐density lipoprotein, body mass index, and weight. Most of our results are inconclusive, and the small sample sizes and the lack of blinding and randomization have led to an increased risk of bias. Pomegranate can decrease menopause symptoms, but more well‐designed studies, with bigger sample sizes are needed to establish its other clinical benefits for menopausal women.